Varex Imaging Corporation reports developments tied to its X-ray imaging component business, including X-ray tubes, digital detectors, connecting devices, imaging software and industrial X-ray systems. Company news commonly covers results from its Medical and Industrial segments, demand trends in CT products, cargo security systems and photon counting detectors, and updates for products used by global OEM manufacturers in medical, industrial and security imaging applications.
Recurring announcements also include earnings releases and conference calls, investor conference participation, and capital-structure actions such as the refinancing of secured debt and redemption of senior secured notes.
Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 of fiscal year 2021 on May 4, 2021, after market close. A conference call is scheduled for the same day at 3:00 p.m. Mountain Time, accessible through the company's website or via phone. Varex specializes in X-ray imaging components and has over 70 years of innovation, providing solutions for medical, industrial, and security imaging applications. The company employs around 2,000 people globally, reflecting its strong presence in the imaging sector.
Varex Imaging Corporation (Nasdaq: VREX) will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 1:10 pm ET. The company’s CFO, Sam Maheshwari, will discuss Varex’s business and future prospects. The presentation will be webcast and accessible on the company’s website, with replays available for 90 days. Varex specializes in designing and manufacturing X-ray imaging components, playing a crucial role in medical and industrial applications, with over 2,000 employees worldwide.
Varex Imaging Corporation (Nasdaq: VREX) reported its 1QFY21 financial results, showing revenues of $177 million, a 4% increase sequentially from 4QFY20. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 34%, reflecting a 580 basis points improvement due to cost reductions and a favorable product mix. GAAP net earnings were $(0.16) per diluted share, while non-GAAP earnings were $0.08. The outlook for 2QFY21 estimates revenues between $180 million and $200 million and non-GAAP earnings per diluted share between $0.05 and $0.25.
Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q1 FY2021 on February 4, 2021, after market close. A conference call is scheduled for 3:00 PM MT the same day, available via webcast on the company’s investor site and through designated phone numbers. The replay will be accessible until February 18, 2021. Varex Imaging specializes in X-ray imaging components, with over 70 years of innovation in medical, industrial, and security applications, employing about 2,000 staff globally.
Varex Imaging Corporation (Nasdaq: VREX) will present at two virtual investor conferences in January 2021. The first is at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021, at 1:35 pm ET. The second presentation is at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 11:30 am ET. CFO Sam Maheshwari will discuss Varex's business and future prospects. Webcast links are available for both events, and replays will be accessible for 90 days on the company's website.
Varex Imaging Corporation (Nasdaq: VREX) announced its 2021 Annual Meeting of Stockholders will be held virtually on February 11, 2021, at 2:00 PM Mountain Time due to COVID-19 restrictions. Stockholders of record as of December 18, 2020, are eligible to vote on meeting matters. Varex will provide necessary information on attending the virtual meeting and encourages stockholders to vote and submit proxies in advance. Varex is a leader in X-ray imaging components, supplying products for medical, industrial, and security applications, employing approximately 2,000 people globally.
Varex Imaging Corporation (Nasdaq: VREX) will present its advanced X-ray technologies at the RSNA 2020, taking place virtually from November 29 to December 5, 2020. Key highlights include intro of nanotube-based X-ray tubes and Liquid Metal Bearing (LMB) X-ray tubes, enhancing efficiency and lifespan. Additionally, Varex will showcase photon counting digital detectors and the Z Platform digital detector, promising improved imaging capabilities. A virtual booth featuring 3D models and product videos will also be launched to engage participants.
Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q4 and fiscal year 2020. Q4 revenues reached $170 million, with a GAAP gross margin of 27% and a net loss of $0.66 per diluted share. For the full year, revenues totaled $738 million, with a GAAP gross margin of 26% and a net loss of $1.47 per diluted share. Despite a decline in sales for some products, Varex noted improved margins due to cost reduction actions. The company expects Q1 FY2021 revenue guidance between $160 million and $180 million.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q4 and fiscal year 2020 on November 17, 2020, post-market close. A conference call will follow at 3:00 PM MT, accessible via the company’s website or by phone. Varex specializes in X-ray imaging components, offering products like X-ray tubes and digital detectors used in medical and security applications, with a workforce of about 2,000 employees worldwide.
Varex Imaging Corporation (Nasdaq: VREX) has completed a private offering of $300 million in 7.875% senior secured notes due 2027 at face value. In conjunction with this, Varex secured a $100 million asset-based revolving credit facility. The funds from the notes will be used to pay off the previous credit facility, alleviating concerns about the company's financial viability. The remaining proceeds will enhance cash reserves for general corporate purposes. This strategic move aims to strengthen Varex's financial position and support its ongoing operations.